Bio-Techne (TECH) Treasury Shares (2013 - 2025)
Bio-Techne's (TECH) quarterly Treasury Shares came in at $831000.0 in Q2 2025, up 67.2% year-on-year from $497000.0 in Q2 2024, and up 67.2% quarter-over-quarter from $497000.0 in Q2 2024.
Bio-Techne (TECH) Treasury Shares (2013 - 2025) Analysis & Trends
Bio-Techne's Treasury Shares history runs 13 years deep, the most recent figure standing at $831000.0 for Q2 2025.
- On a quarterly basis, Treasury Shares rose 67.2% year-over-year to $831000.0 in Q2 2025; TTM through Jun 2025 was $831000.0, a 67.2% increase from a year earlier, with the FY2025 full-year figure at $831000.0, up 67.2% from the prior year.
- Treasury Shares advanced to $831000.0 in Q2 2025 per TECH's latest filing, from $497000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $831000.0 in Q2 2025 and bottomed at $66000.0 in Q2 2022.
- The 5-year median for Treasury Shares is $382000.0 (2021), against an average of $411800.0.
- Across the five-year window, Treasury Shares sank 82.72% in 2022 and surged 328.79% in 2023, its largest moves.
- Year by year, Treasury Shares stood at $382000.0 in 2021, then sank by 82.72% to $66000.0 in 2022, then jumped by 328.79% to $283000.0 in 2023, then soared by 75.62% to $497000.0 in 2024, then surged by 67.2% to $831000.0 in 2025.
- Per Business Quant, the three latest TECH Treasury Shares figures stand at $831000.0 (Q2 2025), $497000.0 (Q2 2024), and $283000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 831,000.00 |
| Jun 30, 2025 | 831,000.00 |
| Jun 30, 2024 | 497,000.00 |
| Jun 30, 2024 | 497,000.00 |
| Jun 30, 2023 | 283,000.00 |
| Jun 30, 2023 | 283,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Jun 30, 2021 | 382,000.00 |
| Jun 30, 2021 | 382,000.00 |
| Jun 30, 2020 | 465,000.00 |
| Jun 30, 2020 | 465,000.00 |
| Jun 30, 2019 | 30,000.00 |
| Jun 30, 2019 | 30,000.00 |
| Jun 30, 2018 | 148,000.00 |
| Jun 30, 2018 | 148,000.00 |
| Jun 30, 2017 | 32,000.00 |
| Jun 30, 2017 | 32,000.00 |
| Jun 30, 2016 | 59,000.00 |
| Jun 30, 2016 | 59,000.00 |